Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Tooth Bleaching Agents
Rats, Inbred LEC
Zisman, Anna L.
He, Yu-Ying
Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).
Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107). Lung Cancer. 2012 Jun; 76(3):393-6.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Antineoplastic Agents
Biomarkers, Tumor
Female
GPI-Linked Proteins
Humans
Male
Mesothelioma
Middle Aged
Phthalazines
Platelet-Derived Growth Factor
Protein Kinase Inhibitors
Pyridines
Survival Analysis
Thrombospondin 1
Treatment Outcome
Vascular Endothelial Growth Factor A
authors with profiles
Hedy Kindler
Everett E. Vokes